BXP's High-Quality CBD Portfolio Should Hold Up Reasonably Well; Maintaining Our $91 Valuation
We are maintaining our $91 per share fair value estimate after incorporating the fourth-quarter results. Our fair value estimate implies a forward 2024 funds from operations multiple of 13 times. Our ...